Taysha Gene Therapies Inc (TSHA) Institutional Ownership Tracker (Q2 2026)

TSHA ranks #2889 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

TSHA is a top-conviction position for GordonMD Global Investments LP — at 11.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in TSHA belongs to California State Teachers Retirement System, but the position matters far more to GordonMD Global Investments LP, who has 11.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Goldman Sachs Group Inc has added to its TSHA position for two straight quarters, increasing it by $79.4M to reach $154.7M today.

Barclays PLC has trimmed its TSHA position for two straight quarters, cutting it by $19.4M while still holding $11.1M.

TSHA is down 3.2% today, but institutions show net buying of $309.4M this quarter — a divergence between today's price move and the underlying institutional flow.

TSHA reported a net loss of $149.6M over the trailing twelve months.

• Not yet profitable — net loss of $149.6M over the trailing twelve months
• Revenue declined 32.3% year over year
• Net income declined year over year, from -$92.7M to -$149.6M
• Operating cash flow was negative, using $93.1M in cash
• Current ratio of 12.23x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.39x equity — within a conventional range